CVS stock plunges after Blue Shield of California drops company’s PBM to save on drug costs

Blue Shield’s announcement hints at the potential for health insurers to abandon the traditional PBM system.

Previous post The Ratings Game: Why Cisco’s stock is rising in the face of a downbeat outlook
Next post : PhenomeX stock rallies by 137% after buyout offer from Bruker